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Introduction
Asparagine-linked glycosylation is an evolutionarily conserved 
protein modification reaction that occurs on N-(X≠P)-T/S/C 
consensus sites (sequons) on newly synthesized proteins in 
the lumen of the ER of eukaryotic cells and on the exoplasmic 
surface of archaebacteria and certain proteobacteria (Larkin and 
Imperiali, 2011). The donor substrate for N-linked glycosylation 
in most eukaryotic organisms is the dolichol pyrophosphate–
linked oligosaccharide GlcNAc2Man9Glc3. The crystal struc-
ture of an acceptor peptide bound to the Campylobacter lari 
PglB, a eubacterial oligosaccharyltransferase (OST), showed 
that the hydroxyamino acid (T/S) in the sequon helps posi-
tion the asparagine next to the active site residues involved 
in catalysis (Lizak et al., 2011). The architecture of the PglB 
active site is consistent with biochemical experiments, indi-
cating that functional acceptor sites must be in unfolded or 
flexible regions of newly synthesized polypeptides (Kowarik 
et al., 2006).
In higher eukaryotes, the OST is a heteroligomeric mem-
brane protein composed of seven to eight nonidentical subunits 
(Kelleher and Gilmore, 2006). The STT3 subunit contains the 
OST active site (Yan and Lennarz, 2002; Nilsson et al., 2003) 
and is the sole OST subunit that is conserved between the eu-
karyotic, archaebacterial, and eubacterial enzymes (Wacker et al., 
2002). Vertebrate, insect, and multicellular plant genomes encode 
two STT3 proteins (STT3A and STT3B; Kelleher et al., 2003). 
The canine and human STT3A and STT3B proteins are incor-
porated into OST complexes that have distinct kinetic properties, 
with the STT3B isoform displaying a reduced stringency of se-
lection of the dolichol pyrophosphate–linked GlcNAc2Man9Glc3 
donor relative to lumenally oriented assembly intermediates 
(dolichol pyrophosphate–linked GlcNAc2Man5-9Glc0-2; Kelleher 
et al., 2003). Selective depletion of STT3A or STT3B in HeLa 
cells via siRNA treatment has shown that the two OST isoforms 
have partially nonoverlapping cellular roles in N-linked gly-
cosylation (Ruiz-Canada et al., 2009). The STT3A isoform is 
associated with the protein translocation channel (Shibatani 
et al., 2005) and mediates co-translational glycosylation of 
NXT/S sites on a nascent polypeptide as it enters the ER lumen 
(Nilsson et al., 2003; Ruiz-Canada et al., 2009). Glycosylation 
of the rapidly folding protein prosaposin is particularly sensi-
tive to STT3A depletion (Ruiz-Canada et al., 2009). The STT3B 
isoform of the OST complex can mediate posttranslational 
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partially nonoverlapping roles in asparagine-linked gly-
cosylation. The STT3A isoform of the OST is primarily re-
sponsible for co-translational glycosylation of the nascent 
polypeptide as it enters the lumen of the endoplasmic re-
ticulum. The C-terminal 65–75 residues of a glycoprotein 
will not contact the translocation channel–associated STT3A 
isoform of the OST complex before chain termination. Bio-
synthetic pulse labeling of five human glycoproteins showed 
that extreme C-terminal glycosylation sites were modi-
fied by an STT3B-dependent posttranslocational mecha-
nism. The boundary for STT3B-dependent glycosylation of 
C-terminal sites was determined to fall between 50 and 
55 residues from the C terminus of a protein. C-terminal 
NXT sites were glycosylated more rapidly and efficiently 
than C-terminal NXS sites. Bioinformatics analysis of gly-
copeptide databases from metazoan organisms revealed 
a lower density of C-terminal acceptor sites in glycopro-
teins because of reduced positive selection of NXT sites 
and negative selection of NXS sites.
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murine glycopeptides, coverage of the murine glycoproteome 
may be as high as 75%. Using this large database of 4,922 high 
confidence murine glycosylation sites that match the N-(X≠P)-
T/S/C sequon, we determined the percentage of modified sites 
that fall within each decile of protein length (Fig. 1 A). As ob-
served previously with smaller glycopeptide datasets (Gavel 
and von Heijne, 1990; Ben-Dor et al., 2004), the N-terminal and 
C-terminal regions of murine glycoproteins have a lower den-
sity of N-linked glycans than internal regions.
Biological explanations for N-terminal or C-terminal re-
ductions in glycan density are obscured by decile analysis be-
cause of the wide range in glycoprotein sequence length. To 
obtain a length-based assessment of glycan distribution, we 
calculated the normalized glycan density (glycans/1,000 amino 
acid residues) in 25-residue increments starting from the C ter-
minus of the murine glycoproteins. The C-terminal regions of 
glycoproteins have 2.5-fold fewer N-linked glycans than inter-
nal regions (Fig. 1 B). The transition between the regions of 
lower and higher glycan density was surprisingly abrupt and 
occurred roughly 75 residues from the C terminus. The NXT/
NXS ratio for the C-terminal glycopeptides was higher than for 
subsequent internal 75 residue blocks, each of which were simi-
lar to the bulk NXT/NXS ratio (Fig. 1 B, inset).
The density of total sequons (NXT/S/C) was reduced in 
the C-terminal 75 residues of the murine glycoproteins (Fig. 1 C). 
Color-coded dashed lines indicate the expected frequency for 
NXT, NXS, or NXC sequons based upon the amino acid compo-
sition of the murine glycoproteins. There is a strong positive se-
lection for NXT sequons and a moderate selection for NXS 
sequons in murine glycoproteins. Examination of the C-terminal 
75 residues revealed reduced positive selection for NXT sites as 
well as negative selection for NXS sites. NXC sites, which are 
modified at a 10-fold lower frequency than NXT sites, are sub-
ject to negative selection regardless of location. The appar-
ent frequency of sequon modification (Fig. 1 D) was calculated 
by dividing the glycan density by the sequon density. Extreme 
C-terminal sequons are modified less frequently than internal 
sequons primarily because of a twofold reduction in the modifi-
cation frequency of NXS sites (Fig. 1 D, inset).
STT3B-dependent glycosylation of extreme 
C-terminal sequons
Secretory proteins and soluble lysosomal proteins were the 
source of 52% of the glycopeptides located in the final 75 resi-
dues of murine glycoproteins. To address the mechanism of 
glycosylation of C-terminal sequons, we selected several secre-
tory or lysosomal glycoproteins for analysis in HeLa cells. Sex 
hormone–binding globulin (SHBG), a 402 residue secreted gly-
coprotein, is an ideal substrate to investigate glycosylation of 
C-terminal sites (Fig. 2 A) because the two secreted forms of 
SHBG differ by having either one or two N-linked oligosaccha-
rides (Bocchinfuso et al., 1992). HeLa cells transfected with 
expression vectors encoding wild-type SHBG or various SHBG 
glycosylation site mutants were pulse labeled and chased for 
0 or 20 min. Wild-type SHBG could be resolved into two major 
polypeptides after pulse–chase labeling (Fig. 2 B). Removal 
of N-linked glycans by endoglycosidase H digestion yielded a 
glycosylation of NXT/S sites that are skipped by the transloca-
tion channel–associated STT3A complex (Ruiz-Canada et al., 
2009). As very few posttranslational glycosylation sites have 
been described (Bolt et al., 2005; Bas et al., 2011; Tamura et al., 
2011), we do not known why certain sequons are skipped by 
STT3A and then modified by STT3B, nor is it known whether 
glycosylation site skipping is a common or rare event.
One class of glycosylation site that might be prone to 
skipping by the STT3A isoform of the OST complex are NXT/S 
sites located near the extreme C terminus of a protein. In vitro 
experiments using ribosome-tethered nascent polypeptides 
indicate that a NXT/S site in a nascent polypeptide first be-
comes accessible to the OST active site when it is located 
65–75 residues from the peptidyltransferase center on the ri-
bosome (Whitley et al., 1996; Nilsson et al., 2003; Deprez et al., 
2005). Movement of a nascent polypeptide past the OST ac-
tive site is limited by the protein synthesis elongation rate, which 
is roughly six residues/second in mammalian cells (Hershey, 
1991). After chain termination, sequons located in the last 65–75 
residues of a protein might move by STT3A more rapidly and 
be skipped. Although these C-terminal glycosylation sites may 
be prone to skipping, modification of such sites can be crit-
ical for proper folding and subsequent vesicular transport 
of secretory proteins (Matzuk and Boime, 1988; McKinnon 
et al., 2010).
Glycosylation sites that are inserted into the C-terminal 
epitope tags of recombinant proteins are posttranslationally gly-
cosylated when expressed in Xenopus laevis oocytes (Pult et al., 
2011). However, it is not known which OST isoform is re-
sponsible for C-terminal glycosylation, nor is it known what 
factors influence the modification efficiency of naturally oc-
curring C-terminal sites. A comprehensive biochemical and 
bioinformatics analysis of naturally occurring C-terminal gly-
cosylation sites has not been previously reported. Our bioinfor-
matics analysis of large glycopeptide databases from fungal, 
plant, and metazoan organisms indicates that the efficiency and 
mechanism of glycosylation of extreme C-terminal sites is evo-
lutionarily conserved. Here, we show that extreme C-terminal 
glycosylation sequons in human proteins are glycosylated by an 
STT3B-dependent posttranslocational pathway. The kinetics 
and modification efficiency of C-terminal sites is strongly de-
pendent on the acceptor site sequence. NXT sites are modified 
more rapidly and efficiently than NXS sites by STT3B even 
when both sites are present in the same polypeptide. Glycosyl-
ation sites that are located >50 residues from the C terminus 
show a reduced dependence on STT3B, indicating that 50 resi-
dues can be considered as a boundary for extreme C-terminal 
glycosylation sites.
Results
Bioinformatics analysis of C-terminal 
glycosylation sites
The most comprehensive list of experimentally verified 
N-glycosylation sites for a mammal has been obtained by glycopro-
teomic analysis of four tissues and plasma from mice (Zielinska 
et al., 2010). Based upon detection of previously documented 
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modified (0.7 glycan/site), primarily during the chase period 
(Fig. 2 B, N396Q mutant). Additional mutants were analyzed to 
determine why the kinetics and modification efficiency of the 
N380RS and N396GT site differed. Converting the N380RS into an 
N380RT site (S382T and S382T N396Q mutants) increased both 
the glycosylation rate and extent of site occupancy. Conversely, 
replacing threonine with serine in the N396GT site (T398S and 
T398S N380Q mutants) decreased the rate and extent of gly-
cosylation. These differences in sequon modification (NXT vs. 
NXS) are consistent with the bioinformatics analysis, indicating 
that C-terminal NXS sites are modified less efficiently than in-
ternal NXS sites or C-terminal NXT sites (Fig. 1 D, inset).
Wild-type SHBG and the two single-site mutants were ex-
pressed in HeLa cells that had been transfected with previously 
single more rapidly migrating polypeptide, confirming that the 
SHBG doublet is caused by heterogeneous glycosylation. Most 
of the SHBG chains have a single glycan at the conclusion of 
the 3-min pulse-labeling period, whereas 50% of SHBG chains 
acquire a second glycan during the 20-min chase period. Trim-
ming of glucose residues from N-linked glycans during the 20-min 
chase incubation is responsible for the minor increase in gel 
mobility of monoglycosylated SHBG that occurs during the 
chase incubation (Fig. 2 B, compare 0- and 20-min chase sam-
ples). The two single-site SHBG mutants (N380Q and N396Q) 
were pulse labeled to determine which site was glycosylated 
during each phase of the labeling experiment. The N396GT 
site was efficiently modified, primarily during the initial pulse 
(Fig. 2 B, N380Q mutant). The N380RS site was incompletely 
Figure 1. Bioinformatics analysis of C-terminal glycosylation sites in murine glycoproteins. The murine glycopeptide database consisted of 4,922 glyco-
peptides derived from 1,902 proteins. (A) The location of glycans in murine glycoproteins distributed by decile of protein length. (B) The normalized glycan 
density versus distance in 25-residue increments from the C terminus. The NXT/NXS ratio for glycopeptides versus distance from the C terminus is shown 
in the inset. (C) The sequon density versus distance from the C terminus. Total sequons (NXT/S/C; black squares), NXT sites (blue circles), NXS sites (red 
triangles), and NXC sites (green diamonds) are shown. The 1,902 proteins had 13,326 sequons. Color-coded dashed lines are expected sequon densities 
for murine glycoproteins based upon the amino acid composition of the proteins. (D) Apparent modification efficiency versus distance from the C terminus. 
The inset shows the apparent modification efficiency for NXT and NXS sites in 75 residue increments from the C terminus.
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Figure 2. Posttranslocational glycosylation of SHBG. (A) Diagram of SHBG showing the signal sequence (black), cleavage site (arrowhead), glycosylation 
sites, and disulfide bonds (red lines). (B–G) HeLa cells were treated with no siRNA (B), negative control (NC) siRNA, or siRNAs specific for STT3A or STT3B 
as indicated (C and D) for 48 h before transfection with SHBG expression vectors. Cells were pulse labeled for 3 min (B), 5 min (C), or 2 min (D–G) and 
chased as indicated. EH designates digestion with endoglycosidase H. SHBG glycoforms (0–2 glycans) were immunoprecipitated with anti-SHBG sera and 
resolved by SDS-PAGE. Downward pointing arrowheads (B and D) designate a nonspecific immunoprecipitation product. Values listed below gel lanes 
(B–D) are the mean of two determinations. (E–G) Pulse–chase analysis of wild-type SHBG (E and F) or the N396Q SHBG mutant (G) in cells treated with 
NC siRNA (E and G, top image) or in cells treated with the STT3B siRNA (F and G, bottom image). The percentage of SHBG molecules that have zero to 
two glycans was calculated. Open symbols in G designate STT3B-depleted cells. Symbols in E–G are the mean of two determinations; error bars indicate 
individual data points. Mean values were fit to single or double exponential equations as described in Materials and methods. The indicated molecular 
masses shown in this and subsequent figures are of prestained molecular mass markers electrophoresed on all gels. Avg., average; WT, wild type.
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simultaneously depleted (Fig. 3 C). Depletion of STT3A alone 
did not cause hypoglycosylation of wild-type -GUS or either 
mutant, whereas depletion of STT3B resulted in glycoform 
doublet accumulation for wild-type -GUS and the -GUS123 
mutant (Fig. 3 C). These results indicate that the three internal 
sequons in -GUS can be glycosylated by either OST isoform, 
whereas STT3B is necessary for efficient glycosylation of the 
C-terminal N631ET site.
In vivo biosynthesis of -GUS takes roughly 2 min. A ki-
netic analysis of wild-type -GUS glycosylation showed that 
70% of the translocated -GUS chains were fully glycosylated 
by the end of a 5-min pulse-labeling period (Fig. 3 D). The re-
maining 30% of -GUS chains, which lack a single glycan, 
disappeared during the chase. The nonglycosylated band that 
co-migrates with the endoglycosidase H digestion product is a 
nontranslocated precursor that was excluded from the kinetic 
analysis. Quantification of the pulse–chase experiment (Fig. 3 E, 
squares) yielded a t1/2 of 1.9 ± 0.2 min for posttranslocational 
glycosylation of wild-type -GUS. Pulse–chase analysis of the 
-GUS123 mutant showed that the N631ET site was glycosyl-
ated at a reduced rate (t1/2 = 7.6 ± 4 min) when the internal sites 
were absent (Fig. 3 E, circles). Although STT3B depletion 
strongly inhibited glycosylation of the N631ET site (Fig. 3 D), a 
t1/2 could not be calculated without making an assumption con-
cerning the final extent of modification (Fig. 3 E, triangles). 
Glycosylation of -GUS mutants with one internal site (12, 
13, or 23) is sensitive to STT3B depletion (Fig. 3 F). Pulse–
chase experiments analyzed as in Fig. 3 E showed that a single 
internal glycan, regardless of position (12, 13, or 23), re-
duced the t1/2 for glycosylation of the C-terminal N631ET site 
relative to the -GUS 123 mutant (Fig. 3 G).
C-terminal glycosylation of type II 
membrane proteins
Type II (Ncytosol-Clumenal) membrane proteins are the second most 
abundant class of murine proteins with glycans in their C-terminal 
75 residues (22% of C-terminal glycopeptides). Human CD40 
ligand was selected as an example of a type II membrane pro-
tein with a single C-terminal glycosylation site (Fig. 4 A). Gly-
cosylation of the N240VT site was reduced slightly by STT3B 
depletion in the Myc-DDK– and MycDDK-tagged versions of 
CD40L (Fig. 4 B). Replacing the NVT sequon with an NVS se-
quon (T242S mutant) reduced the modification frequency of 
the site and caused an increase in sensitivity to STT3B depletion.
CD69 has a C-terminal NVT site and an internal NAC site 
(Fig. 4 C). Although depletion of either STT3A or STT3B 
caused reductions in glycosylation of CD69-Myc-DDK, it was 
not clear which site or sites were affected (Fig. 4 D). Elimina-
tion of the NAC site (N111Q mutant) confirmed a previous 
study that heterogeneous glycosylation of CD69 can be ascribed 
to incomplete modification of the N111AC site (Vance et al., 
1997). In the context of the shorter epitope tag (MycDDK), 
glycosylation of the N166VT site was mildly sensitive to STT3B 
depletion but not to STT3A depletion. Replacing the NVT site 
with an NVS site (T168S mutant) reduced the glycosylation of 
N166. Thus, extreme C-terminal sequons in type II membrane 
proteins are also STT3B substrates.
characterized siRNAs that are specific for the STT3A or STT3B 
mRNAs (Ruiz-Canada et al., 2009). A10-fold depletion of STT3A 
did not reduce glycosylation of wild-type SHBG or either single-
site mutant relative to a negative control siRNA (Fig. 2, C and D). 
siRNA-mediated depletion of STT3B, which lowers STT3B 
levels by roughly sixfold (unpublished data; Ruiz-Canada et al., 
2009), reduced glycosylation of wild-type SHBG and both single-
site mutants. Interestingly, the suboptimal N380RS site was more 
sensitive than the N396GT site to the reduction in STT3B levels 
(Fig. 2 D), likely because of the different kinetics of modification. 
Simultaneous depletion of both STT3A and STT3B was similar 
to STT3B depletion alone, indicating that STT3A has little, if any, 
role in glycosylation of SHBG (Fig. 2 C).
A more extensive pulse–chase analysis of SHBG glyco-
sylation was conducted to determine the t1/2 for glycosylation of 
the C-terminal sites (Fig. 2 E). Quantification of the pulse–chase 
data yielded the expected relationship between a nonglyco-
sylated precursor, a monoglycosylated intermediate, and the 
fully glycosylated product. Disappearance of nonglycosylated 
SHBG, which corresponds to glycosylation of the N396GT site 
occurred with a t1/2 of 2 ± 1 min. Accumulation of diglycosyl-
ated SHBG, which is diagnostic of glycosylation of the N380RS 
site, occurred with a t1/2 of 9 ± 2 min. The N396Q mutant was 
analyzed to determine whether the kinetics of glycosylation of 
the N380RS site was influenced by glycosylation of the N396GT 
site (Fig. 2 G, top and bottom, black symbols). The t1/2 for gly-
cosylation of the N380RS site in the N396Q mutant was 7 ± 
2 min, indicating that glycosylation of the two sites is indepen-
dent. Depletion of STT3B reduced the rate and final extent of 
glycosylation of both acceptor sites in wild-type SHBG (Fig. 2 F). 
The calculated t1/2 values for glycosylation of the N396GT site 
and the N380RS site in STT3B-depleted cells increased to 5 and 
>30 min, respectively. Depletion of STT3B reduced the rate of 
glycosylation of the N380RS site by more than fourfold in the 
N396Q mutant (Fig. 2 G, open symbols). Collectively, these 
experiments indicate that the extreme C-terminal sites in SHBG 
are glycosylated by STT3B after the complete polypeptide has 
passed through the protein translocation channel; hence, modi-
fication of these sites is obligatorily posttranslational and mech-
anistically posttranslocational.
Internal glycosylation sites enhance  
C-terminal glycosylation of  
-glucuronidase (-GUS)
Our analysis of the murine glycopeptide database indicated that 
most glycoproteins with an extreme C-terminal glycan have one 
or more internal NXT/S sequons. Human -GUS has three 
internal sites (sequons 1–3) and one C-terminal site (Fig. 3 A, 
sequon 4). Using a Myc-DDK–tagged -GUS construct, we 
confirmed a previous observation (Shipley et al., 1993) that 
mutation of two or three internal NXT/S sites (-GUS23 or 
-GUS123) resulted in the accumulation of glycoform dou-
blets, indicating incomplete modification of N631 (Fig. 3 B). 
These doublets were prominent in the 0-min chase samples 
(-GUS23 and -GUS123) unless the N631ET site (-GUS4) 
was eliminated (Fig. 3 B). -GUS chains lacking 1–4 glycans 
were synthesized by HeLa cells when STT3A and STT3B were 
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Figure 3. Glycosylation of -GUS in siRNA-treated cells. (A) Diagram of -GUS showing the signal sequence (black), proteolytic cleavage sites (arrow-
heads), glycosylation sites, free cysteine residues (red diamonds), and a Myc-DDK tag. The four sequons are numbered 1–4; -GUS mutants lacking one or 
more sequons are designated as -GUSXYZ, in which XYZ is the list of mutated sequons. (B–D) Transfected HeLa cells were pulse labeled for 5 min and 
chased as indicated with (C, D, and F) or without (B) prior treatment with siRNAs. Anti-DDK immunoprecipitates were analyzed by SDS-PAGE to resolve 
-GUS with zero to four N-linked glycans. (D) Pulse–chase analysis of glycosylation of the N631ET site in wild-type (WT) -GUS (top) or -GUS123 (bot-
tom). (E) The percentages of wild-type -GUS chains that have four glycans (squares) or -GUS123 chains that have one glycan (circles and triangles) are 
shown. Triangles designate cells treated with siRNA for STT3B. Symbols in E are the mean of two determinations; error bars indicate individual data points. 
(F) Values shown below F are the mean of two determinations. (G) The kinetics (t1/2 values) of glycosylation of the N631ET site in the 12, 13, and 23 
mutants was determined by pulse–chase analysis as in D and E. The values shown are the t1/2 values obtained by fitting the experimental data to a single 
exponential equation; error bars designate standard deviations. Avg., average; EH, endoglycosidase H; NC, negative control.
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Defining a boundary for C-terminal 
glycosylation
The serum glycoprotein transferrin (Tf) has one internal and 
one C-terminal glycosylation site (Fig. 5 A). Hypoglycosylated 
Tf is a diagnostic marker for the family of diseases known as 
congenital disorders of glycosylation type 1 (CDG-1). Most sub-
types of CDG-1 are caused by incomplete assembly of dolichol 
pyrophosphate–linked GlcNAc2Man9Glc3, the oligosaccharide 
Another role for the STT3B isoform of the OST is to 
glycosylate internal sites that are skipped by STT3A. We con-
structed a CD69 N166Q-MycDDK mutant to determine which 
OST isoform mediates glycosylation of the N111AC site (Fig. 4 D). 
Depletion of either STT3A or STT3B caused a partial reduction 
in N111AC modification, indicating that both STT3A and STT3B 
contribute to the observed, albeit partial, glycosylation of the 
suboptimal N111AC site.
Figure 4. Glycosylation of type II transmembrane proteins in siRNA-treated cells. (A and C) Diagram of the CD40 ligand (A) and CD69 (C) showing the 
transmembrane domain (black), glycosylation sites, disulfide bonds (red lines), and free cysteines (red dots). (B and D) HeLa cells cotransfected with the 
indicated plasmids and siRNAs were pulse labeled for 2 min (B) or 4 min (D) and chased for 20 min. Polypeptides with zero to two N-linked glycans were 
resolved by SDS-PAGE. Values listed below B and D are the mean of two determinations. Avg., average; EH, endoglycosidase H; NC, negative control.
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donor for N-glycosylation (Haeuptle and Hennet, 2009). Mass 
spectroscopy of serum Tf from CDG-1 patients has indicated that 
the C-terminal site is more frequently skipped than the internal 
site (Hülsmeier et al., 2007).
HeLa cells transfected with DDK-His–tagged Tf were 
subjected to pulse–chase analysis to determine whether the 
C-terminal site in Tf undergoes posttranslocational glycosylation 
(Fig. 5 B). Immunoprecipitation of the pulse-labeled samples 
with anti-DDK sera indicated that Tf was fully glycosylated at 
the end of the 5-min pulse. No evidence for posttranslocational 
modification of either sequon was obtained by pulse–chase 
analysis of the two single-site Tf mutants.
Depletion of STT3A plus STT3B resulted in synthesis 
of Tf-DDK-His chains that lack one to two N-linked glycans 
(Fig. 5 C). Monoglycosylated Tf was also produced when STT3A 
was depleted but absent when STT3B was depleted. Analysis of 
the N630Q mutant indicated that the N432KS site was particu-
larly sensitive to STT3A depletion. A subset of the siRNA de-
pletion experiments were conducted using an untagged Tf 
construct (Fig. 5 D) to determine whether STT3B is required for 
glycosylation of the N630VT site when this site is located closer 
(68 residues) to the C terminus. As observed for the DDK-His–
tagged construct, wild-type Tf was sensitive to STT3A deple-
tion. The C-terminal N630VT site (N432Q mutant) was relatively 
insensitive to depletion of either STT3A or STT3B.
To define a boundary for STT3B-dependent posttrans-
locational glycosylation, additional NVT sequons were inserted 
into the Tf-DDK-His construct or the N432Q Tf-DDK-His con-
struct. The I-1, I-2, and I-3 sequons are located 84, 64, and 14 
residues from the C terminus of Tf-DDK-His, respectively 
(Fig. 5 A). The I-1 and I-2 sites were more efficiently glycosyl-
ated than the I-3 site (Fig. 5 E). Depletion of STT3B eliminated 
glycosylation of the I-3 site but did not reduce glycosylation of 
the I-1 or I-2 sites (Fig. 5 F). Truncation of the DDK-His tag by 
11 residues (Tf I-2His) reduced the distance between the in-
serted I-2 site and the C terminus to 53 residues. As the glyco-
sylated form of Tf I-2His co-migrated with wild-type Tf and 
was insensitive to STT3B depletion (Fig. 5 G), it was initially 
unclear whether the inserted site had been modified. Limited 
digestion of the Tf I-2 and Tf I-2His products with endogly-
cosidase H produced a glycan ladder that allows facile counting 
of N-linked glycans (Fig. 5 H). Both the Tf I-2 and Tf I-2His 
product have three N-linked glycans consistent with efficient 
modification of the inserted NVT site.
To obtain a better understanding of the boundary for post-
translocational C-terminal glycosylation, the location of murine 
glycopeptides was plotted as a running sum versus distance 
from the C terminus (Fig. 5 I, top plot). Remarkably, the plotted 
data could be analyzed as two intersecting lines, the slopes of 
which are proportional to the observed glycan density. The cal-
culated intersection point for the two lines is 66 residues, which 
falls within the range of reported distances in amino acid resi-
dues between the peptidyltransferase site on the ribosome and 
the OST active site (Whitley et al., 1996; Deprez et al., 2005). 
The location and STT3B dependence of the C-terminal glyco-
sylation sites in SHBG, -GUS Myc-DDK, Tf, Tf-DDK-His, 
CD40L, CD69, blood coagulation factor VII, and prosaposin 
are plotted on the same abscissa (Fig. 5 I, bottom plot). With 
one noteworthy exception (Fig. 5 I, factor VII, inverted black 
triangle), sequons that show dependence upon STT3B fall on 
the low glycan density arm of the glycopeptide versus distance 
plot. STT3B-independent sites, including those in Tf and prosa-
posin, are located on the high glycan density arm of the plot. 
The I-2His and I-2 sites in Tf fall in an intermediate region 
near the intersection point where the observed glycan density 
begins to exceed the linear regression fit for the low-density 
arm of the plot (Fig. 5 I, gray square and gray circle).
C-terminal glycosylation in  
model eukaryotes
Recently, N-linked glycopeptides from six diverse model or-
ganisms were identified by mass spectrometry (Zielinska et al., 
2012). These databases were analyzed as in Fig. 5 I to deter-
mine the density of sequons and glycans in the C-terminal 
150 residues of glycoproteins (Fig. 6, glycans are blue lines, 
and sequons are red lines). Sequon and glycan densities that 
were calculated by linear regression analysis are shown adja-
cent to each line or pair of intersecting lines. With the excep-
tion of Schizosaccharomyces pombe, there is a reduced density 
of N-glycans in the C-terminal 75 residues of the glycoproteins. 
Reductions in C-terminal glycan density ranged between 1.4-fold 
for Saccharomyces cerevisiae to 2.3–2.5-fold for Drosophila 
melanogaster, Danio rerio, and Mus musculus. With the excep-
tion of Caenorhabditis elegans, the reduced C-terminal glycan 
density is in part explained by a reduced density of C-terminal 
sequons (Fig. 6). We next asked whether NXS sequons, NXT 
sequons, or both were reduced in C-terminal segments of gly-
coproteins (Table 1 and Table 2). For all organisms except 
S. pombe and C. elegans, positive selection of NXT sequons is 
reduced near the C terminus (Table 1), whereas NXS sequons 
are subject to negative selection (Table 2). As observed for M. 
musculus (Fig. 1 D), the apparent modification frequency of 
NXT sequons shows little or no reduction in the C-terminal 75 
residues (Table 1). The modification frequency for C-terminal 
NXS sequons was reduced in all organisms except S. pombe and 
Arabidopsis thaliana (Table 2). Thus, the overall reduction in C-
terminal glycan density in glycoproteins from metazoan organisms 
is caused by a reduction in sequon density and a lower modification 
efficiency of C-terminal NXS sites (Table 2).
The number of eukaryotic STT3 sequences in the protein 
sequence database has increased roughly fivefold since we last 
examined the relationship between eukaryotic STT3 proteins 
(Kelleher and Gilmore, 2006). Using this larger dataset, it is 
now clear that the genomes of all sequenced metazoan organ-
isms, with the exception of species in the genus Caenorhabditis, 
encode both STT3A and STT3B (Fig. S1). The genomes of all 
multicellular plants and some unicellular plants also encode 
two STT3 proteins. One clade of plant STT3 proteins is more 
closely related to metazoan STT3A proteins, whereas the sec-
ond clade is related to protist STT3 proteins. Fungal genomes 
encode a single STT3 protein. Metazoan STT3B proteins, which 
include the STT3 proteins of Caenorhabditis species, are more 
closely related to fungal STT3 proteins. Thus, the three model 
organisms (S. cerevisiae, S. pombe, and C. elegans) that show 
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Figure 5. Glycosylation of Tf in siRNA-treated cells. (A) Diagram of transferrin (Tf) showing the signal sequence (black), glycosylation sites, disulfide bonds 
(red lines), NVT sequon insertion sites (I-1, I-2, and I-3), and C-terminal DDK-His tag. (B–H) Tf-DDK-His was immunoprecipitated with the anti-DDK antibody 
(B, C, and E–H), whereas untagged Tf was immunoprecipitated with the anti-Tf antibody (D). (B) HeLa cells transfected with DDK-His–tagged wild-type Tf 
or Tf single-site mutants (N432Q or N630Q) were pulse labeled for 5 min and chased as indicated. (C and D) Pulse–chase labeling (5-min pulse and 
20-min chase) of DDK-His–tagged Tf (C) or untagged Tf (D) in siRNA-treated HeLa cells. Black line indicates that intervening lanes have been spliced out. 
(E–H) DDK-His–tagged Tf constructs that have NVT insertions were pulse labeled for 10 min with (F and G) or without (E and H) prior treatment of the cells 
with STT3B siRNA. (H) Immunoprecipitated samples were subjected to digestion with endoglycosidase H (EH) for brief periods as indicated to obtain diges-
tion intermediates that were resolved by SDS-PAGE. Values listed below gel lanes (C and F) are the means of two determinations. (I) Murine glycopeptides 
derived from 1,902 proteins are plotted as a running sum (black squares) relative to distance from the C terminus. Linear regression fits (blue lines) of 
the two arms of the curve intersect at a length of 66 residues. Estimates of STT3B dependence of glycosylation of SHBG N396GT (black diamond), SHBG 
N380RS (gray diamond), Tf I-3 (open square), -GUS-Myc-DDK N631ET (open diamond), Tf I-2His (gray square), Tf I-2 (gray circle), untagged Tf N630VT 
(open triangle), Tf I-1 (black square), Tf-DDK-His N630VT (gray triangle), CD40L-MycDDK (open circle), CD69-MycDDK (black circle), factor VII N360IT 
(inverted black triangle), and prosaposin N429ST (black triangle) are shown. Our scaling system is qualitative because STT3B depletions are incomplete. 
The STT3B dependence values are defined as follows based upon the observed reductions in sequon modification in STT3B-depleted cells: >50% reduction 
(+++, strong); 25–50% reduction (++, moderate); 5–25% reduction (+, detectable); and 0–5% reduction (, independent). Values for factor VII N360IT and 
prosaposin N429ST are taken from Ruiz-Canada et al. (2009). The red bar (OST-PT) designates the reported distance in residues between the OST active 
site and the ribosomal peptidyltransferase center. Avg., average; NC, negative control; WT, wild type.
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Figure 6. Glycan and sequon densities in C-terminal regions of glycoproteins from model organisms. (A–F) The location of glycopeptides (open circles, 
blue lines) and sequons (open squares, red lines) in glycoproteins are plotted as running sums versus distance from the C terminus. The number of ana-
lyzed glycoproteins (P), high confidence glycopeptides (GP), and predicted sequons (S) for each organism is as follows: S. cerevisiae (168 P, 485 GP, 
and 1,337 S); S. pombe (245 P, 416 GP, and 1,543 S); C. elegans (988 P, 1,736 GP, and 5,310 S); A. thaliana (1,267 P, 2,164 GP, and 7,503 S); 
D. melanogaster (999 P, 2,208 GP, and 6,604 S); and D. rerio (1,193 P, 2,160 GP, and 7,810 S). In most cases, two lines, intersecting at 70 ± 5 resi-
dues, provided a superior fit compared with a single line. Numerical values adjacent to lines are sequon and glycan densities (sequons or glycans/1,000 
residues) calculated from the slopes of the lines. Intersecting lines are extended to highlight the intersection point.
 o
n
 July 3, 2013
jcb.rupress.org
D
ow
nloaded from
 
Published March 25, 2013
91N-glycosylation of extreme C-terminal sequons • Shrimal et al.
posttranslocational pathway. Our analysis of large glycopro-
tein databases has revealed that C-terminal sequons are not 
uncommon and that C-terminal NXT sites appear to be glyco-
sylated as efficiently as internal NXT sites.
Posttranslocational glycosylation of  
C-terminal acceptor sites
Because of the distance between the peptidyltransferase site and 
the OST active site, sequons in the last 65–75 residues of a pro-
tein are not glycosylated before chain termination (Fig. 7 b). 
Pulse–chase labeling of two secretory proteins (SHBG and 
-GUS) indicated that C-terminal sites located in the last 50 resi-
dues of a protein are prone to be skipped by the translocation 
channel–associated STT3A isoform of the OST complex, hence 
their glycosylation was insensitive to STT3A depletion. Glyco-
sylation of extreme C-terminal NXT sites was rapid (t1/2 of 
2 min) and efficient, whereas glycosylation of the NXS site in 
SHBG was roughly fourfold slower and did not reach comple-
tion. Three important conclusions can be drawn from the pulse–
chase analysis of SHBG glycosylation. The order in which the 
sequons are modified in wild-type SHBG is not determined by 
the least reduction in C-terminal glycan density express a single 
OST catalytic subunit that is more closely related to the STT3B 
isoform responsible for posttranslocational glycosylation of ex-
treme C-terminal sites in human cells.
Discussion
Hypoglycosylation can cause defects in glycoprotein folding, 
secretion, and function that contribute to the pathophysiologi-
cal symptoms displayed by patients that have congenital disorders 
of glycosylation (Haeuptle and Hennet, 2009). Although extreme 
C-terminal sequons are prone to be skipped by the translocon- 
associated STT3A isoform of the OST, these sequons are often 
evolutionarily conserved (e.g., N396 in SHBG and N631 in 
-GUS), indicating that glycans at these positions are important. 
The  subunit of human chorionic gonadotropin (Matzuk and 
Boime, 1988) and von Willebrand factor (McKinnon et al., 
2010) are examples of proteins that have extreme C-terminal 
glycans that are necessary for efficient protein folding and secre-
tion. Here, we have presented evidence that extreme C-terminal 
sequons in proteins are glycosylated by a STT3B-dependent 
Table 1. NXT acceptor sites in eukaryotic glycoproteins
Organism Sequons (observed/expected) Glycan density Apparent modification frequency
 T-sequon C-sequon C-glycan/T-glycan T-glycan/T-sequon C-glycan/C-sequon
 % %
S. cerevisiae 1.8 1.3 0.78 42 47
S. pombe 1.6 1.7 1.15 34 38
C. elegans 1.6 1.5 0.82 38 31
A. thaliana 2.0 1.4 0.73 32 34
D. melanogaster 1.6 1.3 0.74 39 38
D. rerio 1.7 1.2 0.77 31 33
M. musculus 1.9 1.2 0.56 44 37
An observed/expected ratio >1 indicates positive selection for NXT sequons. T-sequon, total NXT sequons; C-sequon, NXT sequons in the C-terminal region (70 ± 
5 residues). The C-sequon density (NXT sequons/1,000 residues) for the C-terminal region was calculated from linear regression fits of plots of NXT sequons 
versus C-terminal distance. Expected sequon densities were calculated using the amino acid composition of the glycoproteins from each species. The density 
(glycans/1,000 residues) of NXT glycans in the C-terminal segment (70 ± 5 residues) of proteins was determined by linear regression of plots of NXT glycopeptides 
versus C-terminal distance. C-glycans, C-terminal glycans; T-glycans, total glycans. The apparent modification frequency was calculated by dividing the glycan 
density by the sequon density. The apparent modification frequency underestimates the actual percent modification caused by incomplete detection of all glyco-
peptides by mass spectrometry.
Table 2. NXS acceptor sites in eukaryotic glycoproteins
Organism Sequons (observed/expected) Glycan density Apparent modification frequency
 T-sequon C-sequon C-glycan/T-glycan T-glycan/T-sequon C-glycan/C-sequon
 % %
S. cerevisiae 0.9 0.7 0.51 27 18
S. pombe 1.0 1.0 1.08 20 22
C. elegans 0.7 0.7 0.63 25 16
A. thaliana 1.1 0.9 0.78 25 26
D. melanogaster 1.0 0.8 0.37 26 13
D. rerio 1.0 0.9 0.56 24 15
M. musculus 1.3 0.9 0.34 36 17
An observed/expected ratio <1 indicates negative selection for NXS sequons. T-sequon, total NXS sequons; C-sequon, NXS sequons in the C-terminal region (70 ± 
5 residues). The C-sequon density (NXS sequons/1,000 residues) for the C-terminal region was calculated from linear regression fits of plots of NXS sequons 
versus C-terminal distance. Expected sequon densities were calculated using the amino acid composition of the glycoproteins from each species. The density 
(glycans/1,000 residues) of NXS glycans in the C-terminal segment (70 ± 5 residues) of proteins was determined by linear regression of plots of NXS glycopeptides 
versus C-terminal distance. C-glycans, C-terminal glycans; T-glycans, total glycans. The apparent modification frequency was calculated by dividing the glycan den-
sity by the sequon density. The apparent modification frequency underestimates the actual percent modification caused by incomplete detection of all glycopeptides 
by mass spectrometry.
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Clearly, factors other than an extreme C-terminal location can 
cause glycosylation sites, such as the N360IT site factor VII to be 
skipped by STT3A.
What prevents complete modification of extreme C-terminal 
glycosylation sites, such as the N380RS site, in SHBG? For a 
slowly modified site, folding of the nascent polypeptide (Fig. 7 g) 
could prevent glycosylation as a result of the architecture of 
the OST active site (Lizak et al., 2011), which can only ac-
commodate an unfolded region of a protein. A second factor 
that could limit posttranslocational glycosylation would be 
diffusion of the nascent polypeptide away from the lumenal 
surface of the ER membrane where the OST is located (Fig. 7 f). 
The distance between the lumenal surface of the ER mem-
brane and the OST active site had been estimated to be 3 nm 
(Nilsson and von Heijne, 1993). However, this value is some-
what greater than the 1.5-nm distance between the acceptor 
peptide binding site and the transmembrane spans of Campy­
lobacter lari PglB (Lizak et al., 2011). Electron microscopy of 
yeast cells indicates that the thickness of ER cisternae in the 
vicinity of membrane bound ribosomes is on average 36 nm 
(West et al., 2011). Thus, roughly 80% of the lumenal volume 
of the ER is outside a narrow zone of glycosylation near the 
lumenal membrane surface. C-terminal sites in glycoproteins 
that are tethered to the membrane by transmembrane spans or 
glycosylphosphatidylinositol anchors would be retained closer to 
the zone of glycosylation, likely explaining why the C-terminal 
sites in the two type II membrane proteins (CD40L and CD69) 
were less sensitive to STT3B depletion than the C-terminal sites 
in -GUS or SHBG.
the direction of nascent polypeptide exit from the translocation 
channel, as the extreme C-terminal N396GT site is modified be-
fore the N380RS site. This observation excludes the possibility 
that glycosylation of C-terminal sites in proteins is achieved 
by reducing the rate of polypeptide egress from the lumenal 
face of the protein translocation channel after termination of 
protein synthesis. Thus, these sites are posttranslocationally 
glycosylated after the completed protein enters the ER lumen 
(Fig. 7 c). Second, our results indicate that the kinetics and 
extent of C-terminal glycosylation is strongly influenced by 
the hydroxyamino acid in the consensus site. Finally, the dif-
ference in modification kinetics of the two extreme C-terminal 
sites in SHBG is not consistent with a scanning mechanism 
wherein a single copy of STT3B engages a nascent polypep-
tide and scans for skipped NXT/S sites.
As the distance between a glycosylation site and the 
C terminus increases, the dependence upon STT3B decreased. 
The N630VT site in Tf, which is 68 residues from the C termi-
nus, is efficiently glycosylated in STT3B-depleted cells. Analy-
sis of several Tf derivatives and -GUS Myc-DDK indicated 
that the boundary for STT3B dependence falls in the vicinity of 
50–55 residues from the C terminus of the protein. Thus, hypo-
glycosylation of Tf by CDG-1 patients is explained by increased 
acceptor site skipping by STT3A in cells that lack the fully as-
sembled oligosaccharide donor rather than a defect in posttrans-
locational glycosylation by STT3B. The previously analyzed 
posttranslational glycosylation site in factor VII (Bolt et al., 
2005; Ruiz-Canada et al., 2009) is well outside the range for 
extreme C-terminal sites (84 residues from the C terminus). 
Figure 7. Posttranslocational glycosylation of extreme C-terminal sequons. (a) Co-translational glycosylation of internal sequons by the STT3A isoform of 
the OST. (b) Extreme C-terminal sequons (C-terminal 50–55 residues) are inaccessible to STT3A before chain termination and are frequently skipped by the 
STT3A complex. (c–e) Skipped sequons (c) can be recognized by the STT3B complex and glycosylated (d) before protein folding (e). (f) Posttranslocational 
glycosylation of extreme C-terminal sites occurs within a zone of glycosylation that is defined by the distance between the luminal surface of the ER mem-
brane and the OST active site. Structural models for the STT3 (PglB) catalytic subunit of the OST complex and the Sec61 translocation channel (SecYE-) 
are embedded in the membrane bilayer and scaled to the mean thickness of an ER cisternae. The PglB and SecYE- structures were rendered with Mac 
PyMOL software using Protein Data Bank file 3RCE (C. lari PglB) and 1RHZ (Methanocaldococcus jannaschii SecYE-). (g) Incomplete glycosylation of an 
extreme C-terminal site could be explained by exit of the nascent protein from the zone of glycosylation or folding of the polypeptide.
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unmodified sequon in a folding-defective form of transthyretin 
directs the malfolded protein into the glycan-dependent branch 
of the ER-associated degradation pathway. It remains to be de-
termined whether this aspect of the ER-associated degradation 
pathway is applicable to other malfolded proteins with silent 
glycosylation sites. These results, collectively with previous 
findings concerning a co-translational role for STT3A (Ruiz-
Canada et al., 2009), indicate that the duplication of the STT3 
gene in metazoan organisms resulted in the evolution of OST 
isoforms with distinct roles in N-glycosylation that together 
facilitate optimal glycosylation of the large number of OST 
substrates that are expressed by higher eukaryotes.
Materials and methods
Cell culture and plasmid or siRNA transfection
HeLa cells (CCL-13; American Type Culture Collection) were cultured in 
10-cm2 dishes at 37°C in DMEM (Gibco), 10% fetal bovine serum with 
100 U/ml penicillin and 100 µg/ml streptomycin. HeLa cells were seeded 
at 30% confluency for siRNA transfection or 80% confluency for plasmid 
transfection in 60-mm dishes and grown for 24 h before transfection with 
siRNA (60 nM negative control, 50 nM STT3A, and 60 nM STT3B) or 8 µg 
plasmid and Lipofectamine 2000 in Opti-MEM (Gibco) using a protocol 
from the manufacturer (Invitrogen). Plasmid transfection was performed after 
48 h of siRNA transfection, and cells were assayed 24 h later. The siRNAs 
specific for the STT3A and STT3B mRNAs were characterized previously 
(Ruiz-Canada et al., 2009). The STT3A siRNAs are 5-GGCCGUUUCUCUCA-
CCGGCdTdT-3 annealed with 5-UCCGGUGAGAGAAACGGCCdTdT-3. 
The STT3B siRNAs are 5-GCUCUAUAUGCAAUCAGUAdTdT-3 annealed 
with 5-CACUGAUUGCAUAUAGAGCdTdT-3. Negative control siRNA 
was purchased from QIAGEN.
The Myc-DDK–tagged -GUS, CD40 ligand, and CD69 expres-
sion vectors were purchased from OriGene. Tf was amplified from an 
OriGene cDNA clone and cloned into a pCMV6-AC-DDK-His vector (Ori-
Gene). The SHBG, N380Q, and N396Q SHBG mutants in the vector 
pRC/cytomegalovirus (Invitrogen) were gifts from G. Hammond (Child 
and Family Research Institute, Vancouver, British Columbia, Canada). Site-
directed mutagenesis was used to generate glycosylation site mutants or 
to introduce a stop codon after the Myc or DDK tags in the expression 
vector. With the exception of the N173NT site in -GUS that was inacti-
vated by the T175A mutation, glycosylation sites were inactivated by as-
paragine to glutamine substitutions.
Radiolabeling and immunoprecipitation of glycoproteins
Cell culture medium was replaced with methionine- and cysteine-free 
DMEM media (Gibco) containing 10% dialyzed fetal bovine serum 20 min 
before the addition of 200 µCi/ml of Tran35S label (PerkinElmer). Pulse- 
labeling periods were terminated by the addition of unlabeled methionine 
(3.75 mM) and cysteine (0.75 mM). Cells from one culture dish at each 
time point were lysed at 4°C by a 30-min incubation with 1 ml radioimmu-
noprecipitation assay lysis buffer or -GUS lysis buffer (10 mM Tris-Cl, 
pH 8.5, 14 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 1 mM MgCl2, 
and protease inhibitor cocktail, as defined in Kelleher et al. [1992]). Cell 
lysates were clarified by centrifugation (2 min at 13,000 rpm) and pre-
cleared by incubation for 2 h with control IgG and a mixture of protein 
A/G–Sepharose beads (Invitrogen). The precleared lysates were incubated 
overnight with protein or epitope tag–specific antibodies followed by 
the addition of a second aliquot of protein A/G–Sepharose beads and 
incubated for 4 h. Beads were washed five times with radioimmunopre-
cipitation lysis buffer or -GUS wash buffer (150 mM Tris-Cl, pH 7.4, 
500 mM NaCl, 0.4% NP-40, and 1% sodium deoxycholate) and twice 
with 10 mM Tris-HCl before eluting proteins with gel loading buffer. 
Antibodies were obtained from the following sources: anti-Tf (Dako), 
anti-DDK (anti-FLAG; Sigma-Aldrich), anti-SHBG (R&D Systems), and anti-
Myc (Santa Cruz Biotechnology, Inc.). As indicated, immunoprecipitated 
proteins were digested with endoglycosidase H (New England Biolabs, 
Inc.). Dry gels were exposed to a phosphor screen (Fujifilm), scanned in 
a laser scanner (Typhoon FLA 9000; GE Healthcare), and quantified 
using AlphaEaseFC (Alpha Innotech).
Internal glycans stimulate 
posttranslocational glycosylation by STT3B
A single internal glycan, regardless of location, was sufficient 
to increase the rate and extent of C-terminal glycosylation of 
the N631ET site in -GUS. A similar enhancement of posttrans-
locational glycosylation by a second glycan was observed for 
two other substrates (factor VII and KCNE1) that we analyzed 
previously (Ruiz-Canada et al., 2009; Bas et al., 2011). A chal-
lenge for the future will be to determine whether posttranslo-
cational delivery of substrates to STT3B is mediated by ER 
chaperones or instead simply occurs by diffusion (Fig. 7 c).
Conserved features of extreme  
C-terminal glycosylation
Analysis of the glycopeptide databases from seven model or-
ganisms revealed both conserved and nonconserved features 
of C-terminal glycosylation. As reported previously, there is 
strong positive selection for NXT sequons in glycoprotein se-
quences for organisms that have the ER–glycoprotein quality 
control pathway (Cui et al., 2009), and this includes all seven 
model organisms analyzed here. The reduction in C-terminal gly-
can density was most pronounced for the M. musculus, D. rerio, 
and D. melanogaster glycoproteins. The organisms that showed 
the least reduction in C-terminal glycan density (S. cerevisiae, 
S. pombe, and C. elegans) showed little or no reduction in 
sequon density between the C-terminal segment and internal 
regions of glycoproteins. Collectively with the phylogenetic 
analysis of STT3 proteins, it appears that posttranslocational 
glycosylation of sequons by an STT3B-like OST complex 
preceded the evolution of a dedicated translocation channel–
associated STT3A complex.
Cellular roles of the STT3A and STT3B 
isoforms of the OST
The STT3A and STT3B isoforms of the OST complex have 
partially nonoverlapping roles in asparagine-linked glycosyl-
ation. The three internal glycosylation sites in -GUS exem-
plify the class of sites that can be modified by either STT3A or 
STT3B, as hypoglycosylation of these internal sites only oc-
curred when expression of both OST isoforms was reduced.
One prominent role of the STT3B complex is to mediate 
glycosylation of sequons that are skipped by the STT3A com-
plex, including those at the extreme C terminus of proteins. For 
reasons that remain to be determined, the translocation channel–
associated STT3A complex skips certain internal sequons. Pre-
viously characterized skipped sites include an N-terminal site in 
cathepsin C adjacent to the signal sequence cleavage site and a 
posttranslocational glycosylation site in blood coagulation fac-
tor VII (Ruiz-Canada et al., 2009). The internal N111AC site in 
CD69 is frequently skipped by STT3A, as NXC sites are inher-
ently suboptimal because of a reduced binding affinity of the 
acceptor sequon to the OST active site (Bause, 1984). The N111AC 
site is also poorly modified by the STT3B complex, hence oc-
cupancy of this site remains low.
A novel role for the STT3B isoform of the OST in the 
ER-associated degradation pathway was recently described (Sato 
et al., 2012). Posttranslational glycosylation of a normally 
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Analysis of SHBG and -GUS pulse–chase experiments
The pulse–chase data for -GUS and SHBG glycosylation was fit to single 
and double exponential equations using Kaleidograph 3.6 (Synergy Soft-
ware). For wild-type SHBG, which has two glycans, consumption of SHBG-0 
was fit to the equation y = a0 × e(0.693t/t1/2(0)) + b0; formation of SHBG-2 
was fit to the equation y = a2 × (1  e(0.693t/t1/2(2)) + b2. Consumption 
of SHBG-1 was fit to the equation y = a0 × e(0.693t/t1/2(0)) + a2 × (1  
e(0.693t/t1/2(2)) + b1 using the parameters derived for SHBG-0 and SHBG-2 
(a0, a2, t1/2(0), and t1/2(2)).
Bioinformatics analysis of glycoproteomic databases and STT3 proteins
A list of 5,052 high confidence (class I) murine N-glycosylation sites was 
obtained from the supplemental materials in Zielinska et al. (2010). We 
excluded 112 sites that did not match the currently accepted consensus 
sequon (N-X-T/S/C), as current evidence indicates that nonsequons, 
when modified, show occupancy levels that do not exceed 1–3% (Valliere-
Douglass et al., 2009, 2010). 18 additional putative glycopeptides were 
excluded because they map to proteins that do not enter the secretory 
pathway (12 sites) or are no longer in the murine protein database as a re-
sult of a change in open reading frame annotation (six sites). The remain-
ing 4,922 class I sites are in 1,902 murine proteins. The glycoprotein 
sequences were downloaded, and the locations of the glycopeptides were 
verified. When several nonidentical protein sequence files were obtained 
for a given glycopeptide, we selected the file with the largest open reading 
frame to avoid duplication (for alternatively spliced proteins) or analysis of 
incomplete protein sequences (N- or C-terminal truncations). The amino 
acid compositions of the 1,902 glycoproteins were used to calculate ex-
pected sequon densities. A complete list of 13,326 sequons (N-(X≠P)-T/S/C) 
in the 1,902 murine proteins was generated.
High confidence (class I) sites for S. cerevisiae, S. pombe, C. elegans, 
D. melanogaster, A. thaliana, and D. rerio were obtained from the supple-
mental materials in Zielinska et al. (2012) and analyzed in a similar manner. 
The generated sequon lists for all model organisms except M. musculus only 
included N-(X≠P)-T/S sequons because of the low number of N-X-C–linked 
glycans in the initial class I site databases of these model organisms.
Direct retrieval and BLAST (Basic Local Alignment Search Tool) 
search on the NCBI Protein and UniProt databases retrieved 999 eukary-
otic STT3 sequences. Of these, 369 sequences were left after elimina-
tion of duplicates and severely truncated sequences. For display purposes 
(Fig. S1), the collection of 369 STT3 sequences was trimmed to 152 se-
quences representing diverse eukaryotes yet retaining multiple nonidentical 
STT3 sequences from selected metazoan, plant, and protists organisms. Phy-
logenetic alignment of the complete dataset (369 STT3 sequences) yielded a 
similar tree. The 152 sequences were used for phylogenetic analysis on the 
SATCHMO-JS web server (Hagopian et al., 2010). The tree drawing was 
performed using the ETE (python environment for phylogenetic tree explo-
ration) program (Huerta-Cepas et al., 2010).
Online supplemental material
Fig. S1 shows the phylogenetic analysis of eukaryotic STT3 proteins. Table 
S1 lists the accession numbers of the 152 STT3 proteins that were used to 
generate Fig. S1. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.201301031/DC1.
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Table S1 shows accession numbers of STT3 proteins and is provided online as an Excel file.
Figure S1.  Phylogenetic analysis of eukaryotic STT3 proteins. Eukaryotic STT3 protein sequences were downloaded from NCBI Protein database and 
aligned on the SATCHMO-JS web server. Accession numbers of the 152 STT3 protein sequences shown in this figure are listed in Table S1. Segments of 
the alignment are color coded as follows: protists, white; plants, green and yellow; metazoan STT3A proteins, lavender; metazoan STT3B proteins, pink; 
and fungal STT3 proteins, beige.
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